Meier-Gorlin syndrome Clinical genetics and genomics

التفاصيل البيبلوغرافية
العنوان: Meier-Gorlin syndrome Clinical genetics and genomics
المؤلفون: De Munnik, Sonja A., Hoefsloot, Elisabeth H., Roukema, Jolt, Schoots, Jeroen, Knoers, Nine Vam, Brunner, Han G., Jackson, Andrew P., Bongers, Ernie Mhf
المصدر: Orphanet Journal of Rare Diseases, 10(1). BioMed Central
سنة النشر: 2015
مصطلحات موضوعية: Medicine(all), Pre-replication complex, Short stature, Origin recognition complex, Microtia, Journal Article, Ear patella short stature syndrome, Patellar a-/hypoplasia, Genetics(clinical), Pharmacology (medical), Meier-Gorlin syndrome, Review
الوصف: Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients.
وصف الملف: image/pdf
اللغة: English
تدمد: 1750-1172
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7266e32d3dc8147a55b50d4b7b2895f7
https://dspace.library.uu.nl/handle/1874/331889
حقوق: OPEN
رقم الأكسشن: edsair.dedup.wf.001..7266e32d3dc8147a55b50d4b7b2895f7
قاعدة البيانات: OpenAIRE